hypoglycemia

(redirected from Hypoglycemic agents)
Also found in: Thesaurus, Medical, Encyclopedia.

hy·po·gly·ce·mi·a

 (hī′pō-glī-sē′mē-ə)
n.
An abnormally low level of glucose in the blood.

hy•po•gly•ce•mi•a

(ˌhaɪ poʊ glaɪˈsi mi ə)

n.
an abnormally low level of glucose in the blood.
[1890–95; hypo- + glyc(o)- + -emia]
hy`po•gly•ce′mic, adj.

hy·po·gly·ce·mi·a

(hī′pō-glī-sē′mē-ə)
An abnormally low level of sugar in the blood, usually caused by too much insulin and resulting in weakness and dizziness.

hypoglycemia

a condition in which the level of glucose in the blood is abnormally low. — hypoglycemic, adj.
See also: Disease and Illness

hypoglycemia

Low blood sugar, which can cause anxiety, tremors, weakness, and even unconsciousness and death.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hypoglycemia - abnormally low blood sugar usually resulting from excessive insulin or a poor diet
insulin reaction, insulin shock - hypoglycemia produced by excessive insulin in the system causing coma
symptom - (medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease
hyperglycaemia, hyperglycemia - abnormally high blood sugar usually associated with diabetes
Translations
hypoglykemiamatala verensokeri
blóðsykurskortur
hipoglicemia

hy·po·gly·ce·mi·a

n. hipoglicemia, hipoglucemia, disminución anormal del contenido de glucosa en la sangre.

hypoglycemia

n hipoglucemia
References in periodicals archive ?
Muhammad Yaqoob Ahmedani discussed Role of oral Hypoglycemic agents in the Management of Type 2 Diabetes.
Professor Muhammad Yakoob Ahmedani, Professor of Medicine and Consultant Endocrinologist at Baqai Institute of Diabetes and Endocrinology, spoke on the topic of 'Role of Hypoglycemic Agents in the Management of Type 2 Diabetes'.
The adherence rate to all oral hypoglycemic agents (OHAs) over the preceding week was 81.
To determine the magnitude and mechanisms of response to Medicare Part D cost sharing by low-income subsidy (LIS) recipients using oral hypoglycemic agents (OHAs) and statins.
The objective of this study was to determine the effects of zinc supplementation on fasting blood glucose and HbA1c% in adult diabetic patients on oral hypoglycemic agents.
Oral hypoglycemic agents are the group of drugs taken to lower the blood glucose level of a person with Type 2 diabetes; the medication is rarely used to treat Type 1 diabetes.
4), when appropriate, report the new added code for use of hypoglycemic agents (Z79.
Group A was treated with Pioglitazone along with other hypoglycemic agents while group B was treated with only hypoglycemic agents and multivitamin tablets were added as placebo.
The preparations were taken alone, or concurrently with oral hypoglycemic agents, with or without insulin.
More patients taking liraglutide than placebo were able to reduce their use of oral hypoglycemic agents.
1% were taking insulin, 6% were taking both oral hypoglycemic agents and insulin, and 1.